Literature DB >> 28347758

Structure-activity relationships of flavonoids as natural inhibitors against E. coli β-glucuronidase.

Zi-Miao Weng1, Ping Wang2, Guang-Bo Ge3, Zi-Ru Dai3, Da-Chang Wu1, Li-Wei Zou2, Tong-Yi Dou3, Tong-Yan Zhang4, Ling Yang2, Jie Hou5.   

Abstract

Bacterial β-glucuronidases play key roles in the deconjugation of a variety of endogenous and drug glucuronides, thus have been recognized as important targets to modulate the enterohepatic circulation of various glucuronides. In this study, more than 30 natural flavonoids were collected and their inhibitory effects against E. coli β-glucuronidase (EcGUS) were assayed. The results demonstrated that some flavonoids including scutellarein, luteolin, baicalein, quercetin and scutellarin displayed strong to moderate inhibitory effects against EcGUS, with the IC50 values ranging from 5.76 μM to 29.64 μM, while isoflavones and dihydroflavones displayed weak inhibitory effects against EcGUS. Further investigation on inhibition kinetics revealed that scutellarein and luteolin functioned as potent competitive inhibitors against EcGUS-mediated PNPG hydrolysis, with the Ki values less than 3.0 μM. Molecular docking simulations demonstrated that scutellarein and luteolin could be well-docked into the catalytic site of EcGUS, while the binding areas of these two natural inhibitors on EcGUS were highly overlapped with that of PNPG on EcGUS. Additionally, the structure-inhibition relationships of natural flavonoids against EcGUS are also summarized, which will be very helpful for the medicinal chemists to design and develop more potent flavonoid-type inhibitors against EcGUS.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  E. coli β-glucuronidases; Flavonoids; Luteolin; Scutellarein; Structure-inhibition relationships

Mesh:

Substances:

Year:  2017        PMID: 28347758     DOI: 10.1016/j.fct.2017.03.042

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  12 in total

1.  Factors Compromising Glucuronidase Performance in Urine Drug Testing Potentially Resulting in False Negatives.

Authors:  L Andrew Lee; Amanda C McGee; Pongkwan Sitasuwan; John J Tomashek; Chris Riley; Ana Celia Muñoz-Muñoz; Lawrence Andrade
Journal:  J Anal Toxicol       Date:  2022-07-14       Impact factor: 3.220

Review 2.  Therapeutic significance of β-glucuronidase activity and its inhibitors: A review.

Authors:  Paul Awolade; Nosipho Cele; Nagaraju Kerru; Lalitha Gummidi; Ebenezer Oluwakemi; Parvesh Singh
Journal:  Eur J Med Chem       Date:  2019-12-04       Impact factor: 6.514

3.  Cinnamic acid derivatives: inhibitory activity against Escherichia coli β-glucuronidase and structure-activity relationships.

Authors:  Xing-Nuo Li; Lu-Xia Hua; Tao-Shun Zhou; Ke-Bo Wang; Yuan-Yuan Wu; Mahmoud Emam; Xiao-Ze Bao; Jun Chen; Bin Wei
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

Review 4.  Flavonoids Seen through the Energy Perspective.

Authors:  Zhengwen Li; Ming Zhang; Guido R M M Haenen; Lily Vervoort; Mohamed Moalin
Journal:  Int J Mol Sci       Date:  2021-12-24       Impact factor: 5.923

Review 5.  Pharmacokinetic, Metabolism, and Metabolomic Strategies Provide Deep Insight Into the Underlying Mechanism of Ginkgo biloba Flavonoids in the Treatment of Cardiovascular Disease.

Authors:  Yi Tao; Fei Zhu; Meiling Pan; Qing Liu; Ping Wang
Journal:  Front Nutr       Date:  2022-03-23

6.  Comparison of the inhibition potentials of icotinib and erlotinib against human UDP-glucuronosyltransferase 1A1.

Authors:  Xuewei Cheng; Xia Lv; Hengyan Qu; Dandan Li; Mengmeng Hu; Wenzhi Guo; Guangbo Ge; Ruihua Dong
Journal:  Acta Pharm Sin B       Date:  2017-09-01       Impact factor: 11.413

7.  Targeted inhibition of gut bacterial β-glucuronidase activity enhances anticancer drug efficacy.

Authors:  Aadra P Bhatt; Samuel J Pellock; Kristen A Biernat; William G Walton; Bret D Wallace; Benjamin C Creekmore; Marine M Letertre; Jonathan R Swann; Ian D Wilson; Jose R Roques; David B Darr; Sean T Bailey; Stephanie A Montgomery; Jeffrey M Roach; M Andrea Azcarate-Peril; R Balfour Sartor; Raad Z Gharaibeh; Scott J Bultman; Matthew R Redinbo
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-13       Impact factor: 11.205

8.  Anti-Inflammatory Activity of Some Characteristic Constituents from the Vine Stems of Spatholobus suberectus.

Authors:  Xiao-Yan Liu; You-Bo Zhang; Xiu-Wei Yang; Yan-Fang Yang; Wei Xu; Wei Zhao; Kai-Feng Peng; Yun Gong; Ni-Fu Liu; Peng Zhang
Journal:  Molecules       Date:  2019-10-17       Impact factor: 4.411

9.  Inhibition of human carboxylesterases by ginsenosides: structure-activity relationships and inhibitory mechanism.

Authors:  Zhao-Hui Sun; Jing Chen; Yun-Qing Song; Tong-Yi Dou; Li-Wei Zou; Da-Cheng Hao; Hai-Bin Liu; Guang-Bo Ge; Ling Yang
Journal:  Chin Med       Date:  2019-12-16       Impact factor: 5.455

10.  Thiazolidin-2-cyanamides derivatives as novel potent Escherichia coli β-glucuronidase inhibitors and their structure-inhibitory activity relationships.

Authors:  Tao-Shun Zhou; Bin Wei; Min He; Ya-Sheng Li; Ya-Kun Wang; Si-Jia Wang; Jian-Wei Chen; Hua-Wei Zhang; Zi-Ning Cui; Hong Wang
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.